Trials / Conditions / Normal Hepatic Function

Normal Hepatic Function

8 registered clinical trials studyying Normal Hepatic Function — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants NCT07250633	Institut de Recherches Internationales Servier (I.R.I.S.)	Phase 1
Not Yet Recruiting	Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects NCT07055412	Neurodawn Pharmaceutical Co., Ltd.	Phase 1
Completed	A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in H NCT02871570	GlycoMimetics Incorporated	Phase 1
Completed	A Study to Assess the Effects of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intra NCT02611505	Janssen Research & Development, LLC	Phase 1
Completed	Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011 NCT02388620	Novartis Pharmaceuticals	Phase 1
Completed	Effect of Hepatic Impairment on LDK378 Pharmacokinetics NCT01950481	Novartis Pharmaceuticals	Phase 1
Completed	A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerab NCT02138162	Astellas Pharma Europe B.V.	Phase 1
Completed	Effect of Hepatic Impairment on LDE225.. NCT01764776	Novartis Pharmaceuticals	Phase 1